• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白 90 抑制剂通过抑制热刺激的 SK-MEL-2 人黑色素瘤细胞系中的 AKT 通路增强细胞凋亡。

Heat shock protein 90 inhibitor enhances apoptosis by inhibiting the AKT pathway in thermal-stimulated SK-MEL-2 human melanoma cell line.

机构信息

Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

出版信息

J Dermatol Sci. 2018 Jun;90(3):357-360. doi: 10.1016/j.jdermsci.2018.02.004. Epub 2018 Feb 8.

DOI:10.1016/j.jdermsci.2018.02.004
PMID:29433909
Abstract

BACKGROUND

Heat shock proteins (Hsps) are chaperone proteins, which are upregulated after various stresses. Hsp90 inhibitors have been investigated as adjuvant therapies for the treatment of melanoma. Thermal ablation could be a treatment option for surgically unresectable melanoma or congenital nevomelanocytic nevi, however, there is a limitation such as the possibility of recurrence.

OBJECTIVE

We evaluated apoptosis in a melanoma cell line treated with the Hsp90 inhibitor 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), in hyperthermic conditions.

METHODS

SK-MEL-2 cells were stimulated at 43 °C for 1 h and treated with 0, 0.1 and 1 μM 17-DMAG. We evaluated the cell viability using MTT and apoptosis with HSP 90 inhibitor. We studied the protein expression of AKT, phospho-AKT, ERK, phospho-ERK, MAPK, and phospho-MAPK, caspase 3,7,9, and anti-poly (ADP-ribose) polymerase.

RESULTS

17-DMAG significantly inhibited the proliferation of the SK-MEL-2 cells at 37 °C (0.1 μM: 44.47% and 1 μM: 61.23%) and 43 °C (0.1 μM: 49.21% and 1 μM: 63.60%), suggesting synergism between thermal stimulation and 17-DMAG. 17-DMAG treatment increased the frequency of apoptotic cell populations to 2.17% (0.1 μM) and 3.05% (1 μM) in 37 °C controls, and 4.40% (0.1 μM) and 4.97% (1 μM) in the group stimulated at 43 °C. AKT phosphorylation were activated by thermal stimulation and inhibited by 17-DMAG.

CONCLUSION

Hsp90 inhibitor treatment may be clinically applicable to enhance the apoptosis of melanoma cells in hyperthermic condition.

摘要

背景

热休克蛋白(Hsps)是伴侣蛋白,在各种应激后上调。Hsp90 抑制剂已被研究作为治疗黑色素瘤的辅助治疗。热疗消融可以作为手术不可切除的黑色素瘤或先天性神经黑色素痣的治疗选择,然而,存在着复发的可能性等局限性。

目的

我们评估了在 HSP90 抑制剂 17-DMAG 处理下,在高温条件下黑色素瘤细胞系中的细胞凋亡。

方法

SK-MEL-2 细胞在 43°C 下刺激 1 小时,并用 0、0.1 和 1µM 17-DMAG 处理。我们使用 MTT 评估细胞活力,使用 HSP90 抑制剂评估细胞凋亡。我们研究了 AKT、磷酸化 AKT、ERK、磷酸化 ERK、MAPK 和磷酸化 MAPK、caspase 3、7、9 和多聚(ADP-核糖)聚合酶的蛋白表达。

结果

17-DMAG 显著抑制 SK-MEL-2 细胞在 37°C(0.1µM:44.47%和 1µM:61.23%)和 43°C(0.1µM:49.21%和 1µM:63.60%)的增殖,表明热刺激和 17-DMAG 之间存在协同作用。17-DMAG 处理将细胞凋亡的频率从 37°C 对照组的 2.17%(0.1µM)和 3.05%(1µM)增加到 4.40%(0.1µM)和 4.97%(1µM),在 43°C 刺激组中。AKT 磷酸化被热刺激激活,并被 17-DMAG 抑制。

结论

Hsp90 抑制剂的治疗可能在临床上适用于增强高温条件下黑色素瘤细胞的凋亡。

相似文献

1
Heat shock protein 90 inhibitor enhances apoptosis by inhibiting the AKT pathway in thermal-stimulated SK-MEL-2 human melanoma cell line.热休克蛋白 90 抑制剂通过抑制热刺激的 SK-MEL-2 人黑色素瘤细胞系中的 AKT 通路增强细胞凋亡。
J Dermatol Sci. 2018 Jun;90(3):357-360. doi: 10.1016/j.jdermsci.2018.02.004. Epub 2018 Feb 8.
2
17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.17-AAG和17-DMAG通过下调野生型B-Raf表达的葡萄膜黑色素瘤细胞系中的B-Raf来抑制细胞增殖。
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2348-56. doi: 10.1167/iovs.07-1305. Epub 2008 Feb 15.
3
Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.热休克蛋白90(Hsp90)抑制在体外和体内对宫颈癌细胞诱导凋亡及抑制生长的疗效。
Cancer Chemother Pharmacol. 2008 Apr;61(4):669-81. doi: 10.1007/s00280-007-0522-8. Epub 2007 Jun 20.
4
17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.17-二甲基氨基乙氧基甲基-17-去甲氧基格尔德霉素诱导人膀胱癌细胞中热休克蛋白90功能受损:消除恶性肿瘤的标志性特征。
Tumour Biol. 2016 May;37(5):6861-73. doi: 10.1007/s13277-015-4544-2. Epub 2015 Dec 11.
5
The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.HSP90 抑制剂 17-DMAG 在肝癌细胞中的凋亡作用及相关信号转导。
Cell Biol Int. 2012 Oct 1;36(10):893-9. doi: 10.1042/CBI20110473.
6
Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.与热休克蛋白 90 抑制剂 17-二甲氨基乙基氨基-17-去甲氧基格尔德霉素(DMAG)和伏立诺他联合治疗:一种针对人类套细胞淋巴瘤(MCL)细胞的高效组合。
Cancer Biol Ther. 2009 Jul;8(13):1273-80. doi: 10.4161/cbt.8.13.8726.
7
Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance.热休克蛋白90抑制剂:克服内分泌抵抗的新治疗模式。
Cancer Res. 2009 Nov 15;69(22):8670-7. doi: 10.1158/0008-5472.CAN-09-1259. Epub 2009 Oct 27.
8
Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma.17AAG 与 PI3K/mTOR 抑制剂 NVP-BEZ235 联合对人黑色素瘤的协同抗肿瘤作用。
Cancer Lett. 2017 Oct 10;406:1-11. doi: 10.1016/j.canlet.2017.07.021. Epub 2017 Aug 1.
9
The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor.热休克蛋白 90 抑制剂 17-DMAG 对 EGFR 酪氨酸激酶抑制剂耐药的非小细胞肺癌的抗增殖作用。
Lung Cancer. 2012 Feb;75(2):161-6. doi: 10.1016/j.lungcan.2011.04.022. Epub 2011 Jul 20.
10
[Study on signal transduction pathway in differentiation and apoptosis of leukemia cells induced by heat shock protein inhibitor].热休克蛋白抑制剂诱导白血病细胞分化和凋亡的信号转导通路研究
Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):677-80.

引用本文的文献

1
Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.热休克蛋白 70 在口腔癌发生中的临床意义及其对口腔鳞状细胞癌患者进展和复发的预测:一项回顾性临床病理研究。
Eur J Med Res. 2023 Oct 27;28(1):464. doi: 10.1186/s40001-023-01433-8.
2
Adverse Effects of High Temperature On Mammary Alveolar Development In Vitro.高温对体外乳腺腺泡发育的不良影响
J Mammary Gland Biol Neoplasia. 2022 Jun;27(2):155-170. doi: 10.1007/s10911-022-09518-6. Epub 2022 May 17.
3
Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases.
哺乳动物的AKT在疾病中线粒体功能方面的新作用。
Aging Dis. 2022 Feb 1;13(1):157-174. doi: 10.14336/AD.2021.0729. eCollection 2022 Feb.
4
The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma.衰老细胞在BRAFi治疗的黑色素瘤获得性耐药和继发性癌症中的作用
Cancers (Basel). 2021 May 7;13(9):2241. doi: 10.3390/cancers13092241.
5
Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.轻度微波消融联合 HSP90 和 TGF-β1 抑制剂增强骨肉瘤的治疗效果。
Mol Med Rep. 2020 Aug;22(2):906-914. doi: 10.3892/mmr.2020.11173. Epub 2020 May 22.
6
The Role of Erythroid Differentiation Regulator 1 (ERDR1) in the Control of Proliferation and Photodynamic Therapy (PDT) Response.红细胞分化调控因子 1(ERDR1)在增殖控制和光动力疗法(PDT)反应中的作用。
Int J Mol Sci. 2020 Apr 9;21(7):2603. doi: 10.3390/ijms21072603.
7
Inhibitors of HSP90 in melanoma.黑色素瘤中的 HSP90 抑制剂。
Apoptosis. 2020 Feb;25(1-2):12-28. doi: 10.1007/s10495-019-01577-1.
8
Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma.热休克蛋白(HSP)10和HSP70表达增加与鼻咽癌预后不良相关。
Cancer Manag Res. 2019 Sep 6;11:8219-8227. doi: 10.2147/CMAR.S218427. eCollection 2019.
9
Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in Clinics.分子伴侣在正常和病理性甲状腺组织及循环外泌体中的免疫形态学模式:在临床中的潜在应用。
Int J Mol Sci. 2019 Sep 11;20(18):4496. doi: 10.3390/ijms20184496.
10
Vorapaxar stabilizes permeability of the endothelial barrier under cholesterol stimulation via the AKT/JNK and NF‑κB signaling pathways.沃拉帕沙通过 AKT/JNK 和 NF-κB 信号通路稳定胆固醇刺激下的内皮屏障通透性。
Mol Med Rep. 2019 Jun;19(6):5291-5300. doi: 10.3892/mmr.2019.10211. Epub 2019 Apr 30.